Celyad Grants To Novartis AG A Non-Exclusive License For Its Allogeneic TCR-Deficient CAR-T Cells Patents Post author:Sam Post published:May 1, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Rumor Alert: AstraZeneca PLC CEO to Become Teva's New Leader July 12, 2017 Anika Therapeutics To Issue Fourth-Quarter 2016 Financial Results And Business Highlights On Wednesday, February 15 February 1, 2017 3 Biopharmas Worth Watching in 2018 January 14, 2018
Anika Therapeutics To Issue Fourth-Quarter 2016 Financial Results And Business Highlights On Wednesday, February 15 February 1, 2017